Stephen Sallan's laboratory and clinical research focuses on the genetic heterogeneity and treatment of the most common malignancy of childhood, acute lymphoblastic leukemia (ALL). The researcher strives to understand the reasons for disease recurrence and drug resistance, develop new, more specific therapies, especially for the 20% of children whose leukemia is not cured by current therapies, and conduct all such research in the context of diminishing the toxicity of treatment. Current endeavors expand our investigations to adolescents and young adults with ALL and also extend the laboratory discoveries to other leukemias and lymphomas.
About Stephen Sallan
Dr. Sallan received his MD from Wayne State University School of Medicine. He completed residencies in pediatrics at the Boston Floating Hospital, Children's Hospital of Philadelphia, and the Hospital for Sick Children, London and a fellowship in pediatric oncology at Children's Hospital Boston and Dana-Farber Cancer Institute.
Dr Sallan received the Distinguished Alumni Award, Wayne State University School of Medicine, the James Carreras Prize for International Pediatrician of the Year, and the Boston Red Sox Biomedical All Star Award.